HAP Trading’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

HAP Trading’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-40,000	Closed	-$98K	–	1599
2019 Q3	$98K	Sell	40,000 -31,500	-44%	-$3.15M	0.01%	616
2019 Q2	$450K	Buy	71,500 +58,100	+434%	+$6.27M	0.03%	351
2019 Q1	$567K	Buy	13,400 +1,700	+15%	+$125K	0.05%	261
2018 Q4	$24K	Sell	11,700 -2,700	-19%	-$117K	﹤0.01%	853
2018 Q3	$29K	Sell	14,400 -500	-3%	-$34.2K	﹤0.01%	703
2018 Q2	$101K	Sell	14,900 -65,100	-81%	-$5.02M	0.01%	579
2018 Q1	$933K	Buy	80,000 +66,400	+488%	+$3.83M	0.05%	233
2017 Q4	$57K	Buy	+13,600	New	+$977K	﹤0.01%	649

HAP Trading's ONCE Position: Q4 2019 in Review

HAP Trading sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 21,739 shares — an estimated $2.11M sold.

HAP Trading first reported a position in ONCE in Q4 2017 and held it in 3 quarters. The position peaked at $3.43M in Q4 2017. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

HAP Trading reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
HAP Trading sold 21,739 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $2.11M.
HAP Trading first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
HAP Trading's Spark Therapeutics, Inc. Common Stock position peaked at $3.43M in Q4 2017.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on HAP Trading's 13F filing for Q4 2019, filed 11 Feb 2020.